Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

Conditions

• Recurrent Non-small Cell Lung Cancer
• Squamous Cell Lung Cancer
• Stage III Non-small Cell Lung Cancer
• Stage IV Non-small Cell Lung Cancer

Interventions

• DRUG: nintedanib

Sponsor

Roswell Park Cancer Institute

Collaborators

• [object Object]
• [object Object]